[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 994385, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 620894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior VP & Chief Development Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 659364, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.84, "open": 2.9299, "dayLow": 2.775, "dayHigh": 3.01, "regularMarketPreviousClose": 2.84, "regularMarketOpen": 2.9299, "regularMarketDayLow": 2.775, "regularMarketDayHigh": 3.01, "payoutRatio": 0.0, "beta": 2.515, "forwardPE": -9.063062, "volume": 4346565, "regularMarketVolume": 4346565, "averageVolume": 4840012, "averageVolume10days": 6888150, "averageDailyVolume10Day": 6888150, "bid": 1.95, "ask": 2.29, "bidSize": 9, "askSize": 4, "marketCap": 423159200, "fiftyTwoWeekLow": 0.85, "fiftyTwoWeekHigh": 3.01, "allTimeHigh": 718500.0, "allTimeLow": 0.5, "fiftyDayAverage": 1.8586, "twoHundredDayAverage": 1.69115, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 365088224, "profitMargins": 0.0, "floatShares": 141749970, "sharesOutstanding": 142442239, "sharesShort": 40466622, "sharesShortPriorMonth": 31792641, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.2841, "heldPercentInsiders": 0.00279, "heldPercentInstitutions": 0.23187, "shortRatio": 8.67, "shortPercentOfFloat": 0.28620002, "impliedSharesOutstanding": 147442240, "bookValue": 0.365, "priceToBook": 7.8630133, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -25942000, "trailingEps": -0.28, "forwardEps": -0.31667, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 1.8989899, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 2.87, "targetHighPrice": 7.5, "targetLowPrice": 6.0, "targetMeanPrice": 6.83333, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 44320000, "totalCashPerShare": 0.311, "totalDebt": 599000, "quickRatio": 7.48, "currentRatio": 8.279, "debtToEquity": 1.313, "returnOnAssets": -0.44897, "returnOnEquity": -0.84334, "freeCashflow": -22079124, "operatingCashflow": -30621000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "corporateActions": [], "postMarketTime": 1766797154, "regularMarketTime": 1766782800, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.31667, "epsCurrentYear": -0.27, "priceEpsCurrentYear": -10.629629, "fiftyDayAverageChange": 1.0113999, "fiftyDayAverageChangePercent": 0.54417294, "twoHundredDayAverageChange": 1.1788499, "twoHundredDayAverageChangePercent": 0.69707, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 0.0034890524, "postMarketPrice": 2.8701, "postMarketChange": 0.0001001358, "regularMarketChange": 0.03, "regularMarketDayRange": "2.775 - 3.01", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4840012, "fiftyTwoWeekLowChange": 2.02, "fiftyTwoWeekLowChangePercent": 2.3764706, "fiftyTwoWeekRange": "0.85 - 3.01", "fiftyTwoWeekHighChange": -0.1400001, "fiftyTwoWeekHighChangePercent": -0.04651166, "fiftyTwoWeekChangePercent": 189.89899, "dividendDate": 1573171200, "regularMarketChangePercent": 1.05634, "regularMarketPrice": 2.87, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]